Stock 4157 TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News TaiGen Biopharmaceuticals Holdings Limited

Equities

4157

KYG866171005

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
15.4 TWD -0.65% Intraday chart for TaiGen Biopharmaceuticals Holdings Limited -6.38% +1.32%
Mar. 15 TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
TaiGen Biopharmaceuticals Turns to Profit in 2021
MT
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2020
CI
TaiGen Biotechnology Company, Limited Partners with GPCR Therapeutics, Inc. to Develop Burixafor & Taigexyn(R)
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019
CI
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4157 Stock
  4. News TaiGen Biopharmaceuticals Holdings Limited